These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16943531)

  • 1. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
    Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
    J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial.
    Crook JM; Gomez-Iturriaga A; Wallace K; Ma C; Fung S; Alibhai S; Jewett M; Fleshner N
    J Clin Oncol; 2011 Feb; 29(4):362-8. PubMed ID: 21149658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving informed consent in clinical trials: successful piloting of a decision aid.
    Juraskova I; Butow P; Lopez AL; Seccombe M; Boyle F; McCarthy N; Forbes JF
    J Clin Oncol; 2007 Apr; 25(11):1443-4; author reply 1444. PubMed ID: 17416867
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
    Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
    J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
    Ihrig A; Keller M; Hartmann M; Debus J; Pfitzenmaier J; Hadaschik B; Hohenfellner M; Herzog W; Huber J
    BJU Int; 2011 Oct; 108(8):1274-8. PubMed ID: 21410634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005.
    Colberg JW; Decker RH; Khan AM; McKeon A; Wilson LD; Peschel RE
    Cancer J; 2007; 13(4):229-32. PubMed ID: 17762756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.
    Akakura K; Suzuki H; Ichikawa T; Fujimoto H; Maeda O; Usami M; Hirano D; Takimoto Y; Kamoto T; Ogawa O; Sumiyoshi Y; Shimazaki J; Kakizoe T;
    Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice between prostatectomy and radiotherapy when men are eligible for both: a randomized controlled trial of usual care vs decision aid.
    van Tol-Geerdink JJ; Willem Leer J; Weijerman PC; van Oort IM; Vergunst H; van Lin EN; Alfred Witjes J; Stalmeier PF
    BJU Int; 2013 Apr; 111(4):564-73. PubMed ID: 22882966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
    Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy.
    Moinpour CM; Hayden KA; Unger JM; Thompson IM; Redman MW; Canby-Hagino ED; Higgins BA; Sullivan JW; Lemmon D; Breslin S; Crawford ED; Southwest Oncology Group
    J Clin Oncol; 2008 Jan; 26(1):112-20. PubMed ID: 18165645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
    Gwede CK; Pow-Sang J; Seigne J; Heysek R; Helal M; Shade K; Cantor A; Jacobsen PB
    Cancer; 2005 Oct; 104(7):1381-90. PubMed ID: 16080181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
    J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing treatment decisions in patients with low risk prostate cancer referred to a brachytherapy clinic.
    Taussky D; Liu A; Abrahamowicz M; Léger-Bélanger E; Bahary JP; Beauchemin MC; Nguyen TV; Donath D; Saad F
    Can J Urol; 2008 Dec; 15(6):4415-20. PubMed ID: 19046495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.
    D'Amico AV; Hui-Chen M; Renshaw AA; Sussman B; Roehl KA; Catalona WJ
    J Urol; 2006 Dec; 176(6 Pt 2):S11-5. PubMed ID: 17084157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case-matched comparison of contemporary radiation therapy to surgery in patients with locally advanced prostate cancer.
    Fletcher SG; Mills SE; Smolkin ME; Theodorescu D
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1092-9. PubMed ID: 16965872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life after radical prostatectomy and low-dose-rate brachytherapy for localized prostate cancer.
    Wyler SF; Engeler DS; Seelentag W; Ries G; Schmid HP
    Urol Int; 2009; 82(1):17-23. PubMed ID: 19172091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferences for sexual information resources in patients treated for early-stage prostate cancer with either radical prostatectomy or brachytherapy.
    Davison BJ; Keyes M; Elliott S; Berkowitz J; Goldenberg SL
    BJU Int; 2004 May; 93(7):965-9. PubMed ID: 15142144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.